Co-Occurrence of and spp. Infections in the Pathogenesis of Gastrointestinal Diseases.
1/5 보강
and spp.
APA
Braksator J, Kofla-Dłubacz A, et al. (2025). Co-Occurrence of and spp. Infections in the Pathogenesis of Gastrointestinal Diseases.. Biomedicines, 13(5). https://doi.org/10.3390/biomedicines13051172
MLA
Braksator J, et al.. "Co-Occurrence of and spp. Infections in the Pathogenesis of Gastrointestinal Diseases.." Biomedicines, vol. 13, no. 5, 2025.
PMID
40426999 ↗
Abstract 한글 요약
and spp. are widespread microorganisms found in the human gastrointestinal tract, often coexisting in the same ecological niche. , a Gram-negative bacterium, is a well-known pathogen responsible for gastritis, peptic ulcers, and gastric cancer. In contrast, fungi, often detected in food, particularly , are generally considered commensal organisms, but can become opportunistic pathogens under certain conditions. Recent studies suggest a possible link between these microorganisms, highlighting a new survival strategy of , that is, its ability to internalize in vacuoles. This phenomenon, confirmed by various microscopic and molecular techniques, may provide with protection against adverse environmental conditions, especially clinically important antibiotic therapy. The basic premise of this theory is the ability of to penetrate vacuoles in fungal cells, which then become a reservoir of infection, allowing the infection to recur. Understanding the interaction between and may offer new insights into the pathogenesis of gastrointestinal diseases and may lead to the development of treatments targeting both organisms simultaneously. The purpose of this article is to review the literature, considering the first observations on this problem in the literature and the current state of knowledge, and to suggest a direction for further research.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives.
- Journey Towards Piloting Helicobacter pylori Screen-and-Treat to Address Health Inequities in Aotearoa New Zealand.
- Gastric intestinal metaplasia: Management and surveillance strategies.
- Practice Tips From the Updated Treatment Guidelines.
- -related non-coding RNAs in gastric cancer screening: Emerging evidence and translational challenges.
- Vitamin D receptor gene polymorphism and its association with the susceptibility to Helicobacter pylori infection in the Egyptian population with hepatocellular carcinoma.